|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation and amortization | |||||
| Amortization of right of use asset | |||||
| Write-off of inventory | |||||
| Write-off of capitalized patents | |||||
| Write-off of property and equipment | |||||
| Gain on lease termination | |||||
| Stock-based compensation | |||||
| Issuance of Stock and Warrants for Services or Claims | |||||
| Decrease (increase) in operating assets: | |||||
| Accounts receivable | |||||
| Inventory | |||||
| Prepaid expenses and other assets | |||||
| Increase (decrease) in operating liabilities: | |||||
| Accounts payable | |||||
| Accrued expenses and other liabilities | |||||
| Lease liability | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchase of property and equipment | |||||
| Acquisition of intangible assets | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Net proceeds from issuance of common stock and pre-funded warrants | |||||
| Exercise of options and warrants | |||||
| Payment of taxes upon vesting of restricted stock units | |||||
| Net cash provided by (used in) financing activities | |||||
| Cash and cash equivalents at beginning of year | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of year | |||||
| Cash and cash equivalents at end of year | |||||
Loading...